Search Results 8431-8440 of 42447 for oral

1. A Study To Evaluate The Safety And Effectiveness Of TT-00420 In Adults With Advanced Cholangiocarcinoma - Mayo Clinic

   Inability to swallow or tolerate oral medication. Has a history or current evidence of any condition, therapy, or laboratory abnormality that, in the ...

2. Otolaryngology (ENT)/Head and Neck Surgery - Doctors - Mayo Clinic

   l laser microsurgery, Fibula free flap, Microvascular surgery, Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer ...

3. Otolaryngology (ENT)/Head and Neck Surgery - Doctors - Mayo Clinic

   l laser microsurgery, Fibula free flap, Microvascular surgery, Oral and throat cancer, Head and neck cancer, Skin cancer, Oropharyngeal cancer, Mouth cancer ...

4. Phase 2 Study Of VGT-309 In Lung Cancer - Mayo Clinic

   - Oral, injectable, implantable, intravaginal, or transdermal hormonal contraceptives, or - Intrauterine device or intrauterine hormone-releasing system

5. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

   Patients who received oral bisphosphonate within ≤ 12 weeks, IV zoledronic acid (Reclast) ≤ 52 weeks, or denosumab ≤ 24 weeks will also be excluded.

6. A Study to Evaluate Yttrium-90 Therapy for Radiation Lobectomy - Mayo Clinic

   Patients with mild claustrophobia are eligible and have the option to take 1mg oral Lorazepam prior to the MRI, if needed;; Allergy to gadolinium-containing ...

7. A Study of Using Palbociclib Combined with Standard Adjuvant Endocrine Therapy versus Standard Adjuvant Endocrine Therapy Alone for Hormone Receptor Positive/ Human Epidermal Growth Factor Receptor 2 Negative Early Breast Cancer - Mayo Clinic

   Must be able and willing to swallow and retain oral medication. Serum or urine pregnancy test must be negative in premenopausal women within 14 days of ...

8. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

   ... oral or intravenous corticosteroids, 6-mercaptopurine, methotrexate or azathioprine OR must either have or have had a history of corticosteroid dependency ...

9. Phase 1 Study to Evaluate the Safety of ATA188 in Subjects With Progressive and Relapsing-Remitting Multiple Sclerosis - Mayo Clinic

   ... oral contraceptives, some intrauterine contraceptive devices, sexual abstinence, or a vasectomized partner, and/or unwilling to refrain from donating eggs ...

10. Headache Clinical Trials - Mayo Clinic Research

    It is believed the data will predict the occurrence of migraine attacks with high accuracy via the mobile phone app. Efficacy, Safety, and Tolerability of Oral ...